BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

14 related articles for article (PubMed ID: 38569992)

  • 1. Biological activity and computational analysis of novel acrylonitrile derived benzazoles as potent antiproliferative agents for pancreatic adenocarcinoma with antioxidative properties.
    Beč A; Persoons L; Daelemans D; Starčević K; Vianello R; Hranjec M
    Bioorg Chem; 2024 Jun; 147():107326. PubMed ID: 38653153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzazole Substituted Iminocoumarins as Potential Antioxidants with Antiproliferative Activity.
    Perin N; Cindrić M; Vervaeke P; Liekens S; Mašek T; Starčević K; Hranjec M
    Med Chem; 2021; 17(1):13-20. PubMed ID: 31849290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study.
    Lončar B; Perin N; Mioč M; Boček I; Grgić L; Kralj M; Tomić S; Stojković MR; Hranjec M
    Eur J Med Chem; 2021 May; 217():113342. PubMed ID: 33751978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
    Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
    Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triazolopyridinyl-acrylonitrile derivatives as antimicrotubule agents: Synthesis, in vitro and in silico characterization of antiproliferative activity, inhibition of tubulin polymerization and binding thermodynamics.
    Briguglio I; Laurini E; Pirisi MA; Piras S; Corona P; Fermeglia M; Pricl S; Carta A
    Eur J Med Chem; 2017 Dec; 141():460-472. PubMed ID: 29055869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel acrylonitrile derived imidazo[4,5-b]pyridines as antioxidants and potent antiproliferative agents for pancreatic adenocarcinoma.
    Boček Pavlinac I; Persoons L; Daelemans D; Starčević K; Vianello R; Hranjec M
    Int J Biol Macromol; 2024 May; 266(Pt 2):131239. PubMed ID: 38569992
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.